ANABV — AnaptysBio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual balance sheet for AnaptysBio, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	6 M
Source:	10-K	10-K	10-K	10-K	10-KT
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	441	391	385	312	164
Net Total Receivables	1.42	6.85	40.8	33.9	31.6
Prepaid Expenses
Total Current Assets	447	407	432	350	198
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20	18.3	16.2	13.9	11.7
Long Term Investments
Other Long Term Assets
Total Assets	610	452	484	364	317
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	26.1	37.4	45.4	38.6	35.4
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	348	364	413	327	306
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	262	88.1	70.9	37.2	10.6
Total Liabilities & Shareholders' Equity	610	452	484	364	317
Total Common Shares Outstanding